- Home
- NRDS vs BVS Comparison
NRDS vs BVS Comparison
Compare NRDS & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NRDS | BVS |
|---|---|---|
| Founded | 2009 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 720.4M | 716.8M |
| IPO Year | 2021 | 2016 |
Fundamental Metrics
Financial Performance| Metric | NRDS | BVS |
|---|---|---|
| Price | $9.58 | $11.45 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 3 |
| Target Price | ★ $15.00 | $14.00 |
| AVG Volume (30 Days) | ★ 722.0K | 632.2K |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 68.42 | ★ 163.46 |
| EPS | ★ 0.29 | 0.04 |
| Revenue | ★ $836,600,000.00 | $568,087,000.00 |
| Revenue This Year | $10.13 | $7.52 |
| Revenue Next Year | $7.11 | $7.06 |
| P/E Ratio | ★ $32.69 | $294.50 |
| Revenue Growth | ★ 21.67 | N/A |
| 52 Week Low | $7.33 | $5.81 |
| 52 Week High | $16.24 | $11.97 |
Technical Indicators
Market Signals| Indicator | NRDS | BVS |
|---|---|---|
| Relative Strength Index (RSI) | 65.82 | 70.51 |
| Support Level | $9.26 | $8.21 |
| Resistance Level | $10.83 | N/A |
| Average True Range (ATR) | 0.32 | 0.51 |
| MACD | 0.15 | 0.30 |
| Stochastic Oscillator | 85.85 | 85.59 |
Price Performance
Historical ComparisonAbout NRDS NerdWallet Inc.
Nerdwallet Inc is a company that provides consumer-driven advice about personal finance through its platform by connecting individuals and small and mid-sized businesses (SMBs) with providers of financial products. The Company's platform comprises three primary components: Editorial and Content Publishing, Marketplace and Referral Services, and Financial Services. It operates in the United States, Canada, and the United Kingdom.
About BVS Bioventus Inc.
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.